SE8107592L - Forpackad farmaceutisk komposition - Google Patents

Forpackad farmaceutisk komposition

Info

Publication number
SE8107592L
SE8107592L SE8107592A SE8107592A SE8107592L SE 8107592 L SE8107592 L SE 8107592L SE 8107592 A SE8107592 A SE 8107592A SE 8107592 A SE8107592 A SE 8107592A SE 8107592 L SE8107592 L SE 8107592L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
packaged pharmaceutical
potassium clavulanate
amoxycillin trihydrate
desiccant
Prior art date
Application number
SE8107592A
Other languages
Unknown language ( )
English (en)
Other versions
SE451668B (sv
Inventor
P J Crowley
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8107592(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE8107592L publication Critical patent/SE8107592L/sv
Publication of SE451668B publication Critical patent/SE451668B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SE8107592A 1977-10-11 1981-12-17 Farmaceutisk komposition innehallande amoxycillintrihydrat, kaliumklavulanat och ett torkmedel i en sluten behallare SE451668B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (2)

Publication Number Publication Date
SE8107592L true SE8107592L (sv) 1981-12-17
SE451668B SE451668B (sv) 1987-10-26

Family

ID=10423254

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7810591A SE435899B (sv) 1977-10-11 1978-10-10 Torr farmaceutisk enhetsdoskomposition
SE8107592A SE451668B (sv) 1977-10-11 1981-12-17 Farmaceutisk komposition innehallande amoxycillintrihydrat, kaliumklavulanat och ett torkmedel i en sluten behallare

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7810591A SE435899B (sv) 1977-10-11 1978-10-10 Torr farmaceutisk enhetsdoskomposition

Country Status (24)

Country Link
US (2) US4441609A (sv)
JP (1) JPS5476831A (sv)
AU (1) AU525089B2 (sv)
BE (1) BE870988A (sv)
CA (1) CA1105385A (sv)
CH (1) CH642258A5 (sv)
DE (1) DE2843318A1 (sv)
FR (1) FR2405711A1 (sv)
GB (1) GB2005538B (sv)
HK (1) HK73785A (sv)
IE (1) IE47450B1 (sv)
IL (1) IL55660A (sv)
IT (1) IT1109273B (sv)
JO (1) JO984B1 (sv)
KE (1) KE3525A (sv)
MT (1) MTP836B (sv)
MY (1) MY8500996A (sv)
NL (1) NL190631B (sv)
NZ (1) NZ188497A (sv)
PL (1) PL210174A1 (sv)
PT (1) PT68600A (sv)
SE (2) SE435899B (sv)
SG (1) SG34985G (sv)
ZA (1) ZA785682B (sv)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
AT353409B (de) * 1975-02-07 1979-11-12 Glaxo Lab Ltd Verfahren zum entfernen von verunreinigungen aus clavulansaeure oder deren salzen
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
NZ194912A (en) 1979-10-02 1983-05-31 Beecham Group Ltd 6 -(2-(2'-methylphenoxycarbonyl)-2-thien-3'-ylacetamido)-penicillanic acid and pharmaceutical compositions
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (fr) * 1986-01-22 1988-12-23 Adir Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles.
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
US5947274A (en) * 1994-08-05 1999-09-07 Smithkline Beecham P.L.C. Desiccating container for moisture-sensitive material
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
KR100495585B1 (ko) 1995-09-07 2005-09-09 스미스클라인비이참피이엘시이 제약 제제
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
IL131201A (en) * 1997-02-14 2005-06-19 Smithkline Beecham Lab Pharmaceutical formulations comprising amoxycillin and clavulanate
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
WO2000025751A2 (en) * 1998-10-30 2000-05-11 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
BR0013366A (pt) * 1999-08-16 2002-07-23 Revaax Pharmaceuticals Llc Métodos para tratar um distúrbio comportamental, um paciente humano, doença de próstata, distúrbios de ansiedade e cognitivos em um paciente humano afligido com uma condição ou disposto ao desenvolvimento de uma condição distinguida pelo menos em parte pela concentração de glutamato extracelular anormal no cérebro ou em outro tecido nervoso, distúrbio comportamental nas espécies humana, canina, felina e equina e um paciente afligido com ou disposto a desenvolver uma doença compreendendo concentrações de glutamato anormalmente elevadas em tecido neuronal ou nìveis de naaladase elevados em tecido prostático e com esclerose múltipla e para realçar a função cognitiva, formulação farmacêutica e usos de um inibidor da atividade de peptidase de uma dipeptidase ácida ligada em alfa n-acetilada e de um composto de beta-lactama
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US20060039967A1 (en) * 2002-08-12 2006-02-23 Motohiro Ohta Amino acid-containing chewable
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
US9458451B2 (en) 2007-06-21 2016-10-04 Gen-Probe Incorporated Multi-channel optical measurement instrument
JP2011500811A (ja) * 2007-10-26 2011-01-06 レクサン ファーマシューティカルズ インコーポレイテッド クラブラン酸の医薬品製剤
JP2012525427A (ja) * 2009-04-29 2012-10-22 レクサン ファーマシューティカルズ インコーポレイテッド 神経保護および神経変性疾患の治療のためのクラブラン酸塩製剤
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus

Also Published As

Publication number Publication date
IT7851415A0 (it) 1978-10-09
US4441609A (en) 1984-04-10
SE451668B (sv) 1987-10-26
GB2005538A (en) 1979-04-25
FR2405711A1 (fr) 1979-05-11
IE47450B1 (en) 1984-03-21
DE2843318A1 (de) 1979-04-12
AU4050678A (en) 1980-04-17
SE435899B (sv) 1984-10-29
FR2405711B1 (sv) 1982-10-29
SG34985G (en) 1985-11-15
AU525089B2 (en) 1982-10-21
PL210174A1 (sv) 1980-08-11
IL55660A (en) 1981-09-13
CA1105385A (en) 1981-07-21
NL7810176A (nl) 1979-04-17
IE782019L (en) 1979-04-11
JO984B1 (en) 1979-12-01
CH642258A5 (de) 1984-04-13
ZA785682B (en) 1979-09-26
HK73785A (en) 1985-10-04
SE7810591L (sv) 1979-04-11
BE870988A (fr) 1979-04-03
JPS6341886B2 (sv) 1988-08-19
PT68600A (en) 1978-10-01
KE3525A (en) 1985-05-31
US4301149A (en) 1981-11-17
JPS5476831A (en) 1979-06-19
MY8500996A (en) 1985-12-31
IL55660A0 (en) 1978-12-17
MTP836B (en) 1979-05-11
NZ188497A (en) 1981-05-01
GB2005538B (en) 1982-05-26
NL190631B (nl) 1994-01-03
IT1109273B (it) 1985-12-16

Similar Documents

Publication Publication Date Title
SE8107592L (sv) Forpackad farmaceutisk komposition
IE812232L (en) Composition
SE8300736D0 (sv) Novel pharmacologically active compounds
SE8303531D0 (sv) Farmaceutisk komposition
ATE198835T1 (de) Knochenwachstumsfördernde zusammensetzung
ES2090368T3 (es) Composiciones farmaceuticas que contienen glucosaminoglicanos absorbibles por via oral.
DE3064910D1 (en) 2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
PH9997A (en) Pharmacologically active n(1h-tetrazol-5-yl)quinaldamide compounds and compositions containing them
ZA773747B (en) Pharmaceutical compositions containing organic derivatives of montmorillonite
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
AU4150489A (en) Micronised drug formulation
GB2021409A (en) Pharmaceutical composition
ATA401872A (de) Bildmischschaltung
GB2258397A (en) Pharmaceutical compositions containing amethocaine
ES368325A1 (es) Un procedimiento para la preparacion de un compuesto de ce-falosporina.
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
EP0003200A3 (en) Use of tetrahydropyridinyl indole derivatives as medicines, and pharmaceutical compositions containing them
KR940000108A (ko) 라이신 클로닉시네이트를 함유하는 약리학적 연질 캡슐 및 그것의 제조 방법
SE7409378L (sv)
KR880005931A (ko) 제약 조성물
SE8804317D0 (sv) Kompositioner foer reduktion av flebektasi jaemte foerfarande foer framstaellning av dessa
GB1294538A (en) Pharmaceutical compositions
GB2012166A (en) Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8107592-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8107592-1

Format of ref document f/p: F